Effect of insulin sensitizer treatment on carotid arterial elasticity
Not Applicable
- Conditions
- type2 diabetes
- Registration Number
- JPRN-UMIN000001085
- Lead Sponsor
- Tohoku University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
severe renal dysfunction severe liver dysfunction heart failure history of lactic acidosis severe retinopathy severe vascular disease with urgent treatment HbA1c over 9% blood pressure over 180/100 mmHg
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change of carotid arterial elasticity
- Secondary Outcome Measures
Name Time Method changes of serum markers of atheroscrerosis,pulse wave velocity and carotid intima-media thickness
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie insulin sensitizer effects on carotid arterial elasticity in type 2 diabetes?
How do pioglitazone and biguanide compare to standard-of-care treatments for vascular complications in type 2 diabetes patients?
Which biomarkers correlate with improved carotid arterial elasticity following insulin sensitizer therapy in type 2 diabetes?
What adverse events are associated with pioglitazone and biguanide combination therapy in type 2 diabetes patients?
How do PPARγ agonists and biguanides synergize in improving arterial stiffness compared to other antidiabetic drug combinations?